U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H19N3
Molecular Weight 265.3529
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ESMIRTAZAPINE

SMILES

[H][C@]12CN(C)CCN1C3=C(CC4=C2C=CC=C4)C=CC=N3

InChI

InChIKey=RONZAEMNMFQXRA-MRXNPFEDSA-N
InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3/t16-/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H19N3
Molecular Weight 265.3529
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:07:07 UTC 2023
Edited
by admin
on Sat Dec 16 17:07:07 UTC 2023
Record UNII
4685R51V7M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ESMIRTAZAPINE
INN   WHO-DD  
INN  
Official Name English
PYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPINE, 1,2,3,4,10,14B-HEXAHYDRO-2-METHYL-, (14BS)-
Systematic Name English
Esmirtazapine [WHO-DD]
Common Name English
ORG-44-20
Code English
(+)-MIRTAZAPINE
Common Name English
(S)-MIRTAZAPINE
Common Name English
S-(+)-MIRTAZAPINE
Common Name English
(S)-6-AZAMIANSERIN
Common Name English
MIRTAZAPINE, (S)-
Common Name English
(14BS)-1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPINE
Common Name English
esmirtazapine [INN]
Common Name English
(S)-ORG 3770
Code English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
NCI_THESAURUS C29756
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL1366933
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
CAS
61337-87-9
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
ECHA (EC/EINECS)
262-714-0
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
DRUG BANK
DB06678
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
INN
8620
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
EPA CompTox
DTXSID001029320
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
PUBCHEM
3085218
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
FDA UNII
4685R51V7M
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
SMS_ID
100000174926
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
NCI_THESAURUS
C76963
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
WIKIPEDIA
ESMIRTAZAPINE
Created by admin on Sat Dec 16 17:07:08 UTC 2023 , Edited by admin on Sat Dec 16 17:07:08 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
ENANTIOMER -> ENANTIOMER
TARGET -> INHIBITOR
TARGET -> INHIBITOR
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE -> PARENT
IN-VIVO
Scientific Literature
Related Record Type Details
ACTIVE MOIETY